Synthesis and antimicrobial activity of geranyloxy- and farnesyloxy-acetophenone derivatives against oral pathogens.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 22698715)

Published in Fitoterapia on June 11, 2012

Authors

Laetitia Bonifait1, Annie Marquis, Salvatore Genovese, Francesco Epifano, Daniel Grenier

Author Affiliations

1: Groupe de Recherche en Écologie Buccale, Faculté de Médecine Dentaire, Université Laval, Québec City, QC, Canada.

Articles by these authors

Virulence factors involved in the pathogenesis of the infection caused by the swine pathogen and zoonotic agent Streptococcus suis. Future Microbiol (2012) 2.10

Continuous subcutaneous glucose monitoring in diabetic patients: a multicenter analysis. Diabetes Care (2002) 1.92

Characterization of Streptococcus suis isolates recovered between 2008 and 2011 from diseased pigs in Québec, Canada. Vet Microbiol (2012) 1.69

In vitro models of tissue penetration and destruction by Porphyromonas gingivalis. Infect Immun (2004) 1.26

Fusobacterium nucleatum increases collagenase 3 production and migration of epithelial cells. Infect Immun (2005) 1.24

Chemistry and pharmacology of oxyprenylated secondary plant metabolites. Phytochemistry (2007) 1.21

Probiotics for oral health: myth or reality? J Can Dent Assoc (2009) 1.11

Fibrinogen induces biofilm formation by Streptococcus suis and enhances its antibiotic resistance. Appl Environ Microbiol (2008) 1.10

Chemical composition, antimicrobial and antioxidant activity of the essential oil of Teucrium marum (Lamiaceae). J Ethnopharmacol (2005) 1.08

Effects of a high-molecular-weight cranberry fraction on growth, biofilm formation and adherence of Porphyromonas gingivalis. J Antimicrob Chemother (2006) 1.07

Loss of lipopolysaccharide receptor CD14 from the surface of human macrophage-like cells mediated by Porphyromonas gingivalis outer membrane vesicles. Microb Pathog (2004) 1.06

Cell surface characteristics of nontypeable isolates of Streptococcus suis. FEMS Microbiol Lett (2010) 1.05

Oral microbial heat-shock proteins and their potential contributions to infections. Crit Rev Oral Biol Med (2003) 1.04

Effect of licorice compounds licochalcone A, glabridin and glycyrrhizic acid on growth and virulence properties of Candida albicans. Mycoses (2011) 1.03

Dietary administration with prenyloxycoumarins, auraptene and collinin, inhibits colitis-related colon carcinogenesis in mice. Int J Cancer (2006) 1.03

Inflammatory responses of a macrophage/epithelial cell co-culture model to mono and mixed infections with Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia. Microbes Infect (2005) 1.03

The cell envelope subtilisin-like proteinase is a virulence determinant for Streptococcus suis. BMC Microbiol (2010) 1.02

Pleiotropic effects of polysaccharide capsule loss on selected biological properties of Streptococcus suis. Can J Vet Res (2010) 1.02

Absence of alphavbeta6 integrin is linked to initiation and progression of periodontal disease. Am J Pathol (2008) 1.01

Chemistry and biological activity of natural and synthetic prenyloxycoumarins. Curr Med Chem (2006) 1.00

Colorectal cancer chemoprevention by 2 beta-cyclodextrin inclusion compounds of auraptene and 4'-geranyloxyferulic acid. Int J Cancer (2010) 1.00

Modulation of cytokine production by Porphyromonas gingivalis in a macrophage and epithelial cell co-culture model. Microbes Infect (2005) 0.98

Identification and characterization of four proteases produced by Streptococcus suis. FEMS Microbiol Lett (2003) 0.95

The SspA subtilisin-like protease of Streptococcus suis triggers a pro-inflammatory response in macrophages through a non-proteolytic mechanism. BMC Microbiol (2011) 0.94

Risk of bacterial resistance associated with systemic antibiotic therapy in periodontology. J Can Dent Assoc (2007) 0.94

Purification and characterization of the subtilisin-like protease of Streptococcus suis that contributes to its virulence. Vet Microbiol (2010) 0.93

Auraptene: a natural biologically active compound with multiple targets. Curr Drug Targets (2011) 0.93

Latest developments on Streptococcus suis: an emerging zoonotic pathogen: part 1. Future Microbiol (2014) 0.92

Phytochemistry and pharmacognosy of the genus Acronychia. Phytochemistry (2013) 0.91

Anti-Porphyromonas gingivalis and anti-inflammatory activities of A-type cranberry proanthocyanidins. Antimicrob Agents Chemother (2010) 0.91

Antioxidant effects of garlic in young and aged rat brain in vitro. J Med Food (2009) 0.91

Antimicrobial activity of nisin against the swine pathogen Streptococcus suis and its synergistic interaction with antibiotics. Peptides (2013) 0.90

Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by Porphyromonas gingivalis in an engineered human oral mucosa model. J Cell Physiol (2007) 0.90

Inhibition of periodontopathogen-derived proteolytic enzymes by a high-molecular-weight fraction isolated from cranberry. J Antimicrob Chemother (2006) 0.89

Latest developments on Streptococcus suis: an emerging zoonotic pathogen: part 2. Future Microbiol (2014) 0.89

Cranberry proanthocyanidins inhibit the adherence properties of Candida albicans and cytokine secretion by oral epithelial cells. BMC Complement Altern Med (2012) 0.89

Tetracyclines and chemically modified tetracycline-3 (CMT-3) modulate cytokine secretion by lipopolysaccharide-stimulated whole blood. Inflammation (2009) 0.89

Protective effects of grape seed proanthocyanidins against oxidative stress induced by lipopolysaccharides of periodontopathogens. J Periodontol (2006) 0.89

A licorice extract reduces lipopolysaccharide-induced proinflammatory cytokine secretion by macrophages and whole blood. J Periodontol (2008) 0.89

Treponema denticola lipooligosaccharide activates gingival fibroblasts and upregulates inflammatory mediator production. J Cell Physiol (2008) 0.88

Isoflavonoids and coumarins from Glycyrrhiza uralensis: antibacterial activity against oral pathogens and conversion of isoflavans into isoflavan-quinones during purification. J Nat Prod (2011) 0.88

Cranberry polyphenols: potential benefits for dental caries and periodontal disease. J Can Dent Assoc (2010) 0.88

Neuroprotective effect of prenyloxycoumarins from edible vegetables. Neurosci Lett (2008) 0.88

Auraptene is an inhibitor of cholesterol esterification and a modulator of estrogen receptors. Mol Pharmacol (2010) 0.88

Cranberry components inhibit interleukin-6, interleukin-8, and prostaglandin E production by lipopolysaccharide-activated gingival fibroblasts. Eur J Oral Sci (2007) 0.88

Upregulation of prostaglandin E2 and matrix metalloproteinase 9 production by human macrophage-like cells: synergistic effect of capsular material and cell wall from Streptococcus suis. Microb Pathog (2005) 0.88

Prenyloxyphenylpropanoids as a novel class of anticonvulsive agents. Bioorg Med Chem Lett (2009) 0.87

Grape seed extract suppresses lipopolysaccharide-induced matrix metalloproteinase (MMP) secretion by macrophages and inhibits human MMP-1 and -9 activities. J Periodontol (2009) 0.87

Porphyromonas gingivalis lipopolysaccharide induces shedding of syndecan-1 expressed by gingival epithelial cells. J Cell Physiol (2005) 0.86

The collagenase activity of Porphyromonas gingivalis is due to Arg-gingipain. FEMS Microbiol Lett (2003) 0.86

Cleavage of human transferrin by Porphyromonas gingivalis gingipains promotes growth and formation of hydroxyl radicals. Infect Immun (2004) 0.86

Actinobacillus actinomycetemcomitans lipopolysaccharide regulates matrix metalloproteinase, tissue inhibitors of matrix metalloproteinase, and plasminogen activator production by human gingival fibroblasts: a potential role in connective tissue destruction. J Cell Physiol (2007) 0.85

Porphyromonas endodontalis in chronic periodontitis: a clinical and microbiological cross-sectional study. J Oral Microbiol (2012) 0.85

Characterization of volatile sulfur compound production by Solobacterium moorei. Arch Oral Biol (2012) 0.85

The plant coumarins auraptene and lacinartin as potential multifunctional therapeutic agents for treating periodontal disease. BMC Complement Altern Med (2012) 0.84

Endothelial cell/macrophage cocultures as a model to study Streptococcus suis-induced inflammatory responses. FEMS Immunol Med Microbiol (2009) 0.84

Acquisition of host plasmin activity by the Swine pathogen Streptococcus suis serotype 2. Infect Immun (2004) 0.84

Modulation of matrix metalloproteinase and cytokine production by licorice isolates licoricidin and licorisoflavan A: potential therapeutic approach for periodontitis. J Periodontol (2010) 0.83

Comparative evaluation of two structurally related flavonoids, isoliquiritigenin and liquiritigenin, for their oral infection therapeutic potential. J Nat Prod (2011) 0.83

Overview of complications secondary to tongue and lip piercings. J Can Dent Assoc (2007) 0.83

Porcine brain microvascular endothelial cell-derived interleukin-8 is first induced and then degraded by Streptococcus suis. Microb Pathog (2008) 0.83

Cranberry proanthocyanidins: natural weapons against periodontal diseases. J Agric Food Chem (2011) 0.82

Priming effect of fibronectin fragments on the macrophage inflammatory response: potential contribution to periodontitis. Inflammation (2012) 0.82

Doxycycline reduces lipopolysaccharide-induced inflammatory mediator secretion in macrophage and ex vivo human whole blood models. J Periodontol (2008) 0.82

Transcriptional approach to study porcine tracheal epithelial cells individually or dually infected with swine influenza virus and Streptococcus suis. BMC Vet Res (2014) 0.81

Peptostreptococcus micros cell wall elicits a pro-inflammatory response in human macrophages. J Endotoxin Res (2007) 0.81

Hemoglobin and Streptococcus suis cell wall act in synergy to potentiate the inflammatory response of monocyte-derived macrophages. Innate Immun (2008) 0.81

Discrimination of metallosupramolecular architectures in solution by using diffusion ordered spectroscopy (DOSY) experiments: double-stranded helicates of different lengths. Chemistry (2006) 0.81

Pyrano-isoflavans from Glycyrrhiza uralensis with antibacterial activity against Streptococcus mutans and Porphyromonas gingivalis. J Nat Prod (2014) 0.81

Synthesis and anti-inflammatory activity of natural and semisynthetic geranyloxycoumarins. Bioorg Med Chem Lett (2004) 0.81

Development and application of high-performance liquid chromatography for the study of two new oxyprenylated anthraquinones produced by Rhamnus species. J Chromatogr A (2012) 0.80

Acquisition of plasmin activity and induction of arachidonic acid release by Streptococcus suis in contact with human brain microvascular endothelial cells. FEMS Microbiol Lett (2005) 0.80

Growth inhibitory activities of oxyprenylated and non-prenylated naturally occurring phenylpropanoids in cancer cell lines. Bioorg Med Chem Lett (2011) 0.80

Effects of Japanese traditional herbal medicines (Kampo) on growth and virulence properties of Porphyromonas gingivalis and viability of oral epithelial cells. Pharm Biol (2013) 0.80

Detection of Streptococcus suis in bioaerosols of swine confinement buildings. Appl Environ Microbiol (2014) 0.80

Systemic antibiotic therapy in the treatment of periodontitis. J Can Dent Assoc (2007) 0.80

3-(4'-geranyloxy-3'-methoxyphenyl)-2-trans propenoic acid: a novel promising cancer chemopreventive agent. Anticancer Agents Med Chem (2006) 0.79

Amoeba host model for evaluation of Streptococcus suis virulence. Appl Environ Microbiol (2011) 0.79

Anthocyanin-rich black currant extract and cyanidin-3-O-glucoside have cytoprotective and anti-inflammatory properties. J Med Food (2012) 0.79

Recent application of analytical methods to phase I and phase II drugs development: a review. Biomed Chromatogr (2011) 0.79

Cytoprotective effect of proanthocyanidin-rich cranberry fraction against bacterial cell wall-mediated toxicity in macrophages and epithelial cells. Phytother Res (2009) 0.79

Antibacterial, antiadherence, antiprotease, and anti-inflammatory activities of various tea extracts: potential benefits for periodontal diseases. J Med Food (2013) 0.79

Natural coumarins as a novel class of neuroprotective agents. Mini Rev Med Chem (2009) 0.79

Prenyloxyphenylpropanoids as novel lead compounds for the selective inhibition of geranylgeranyl transferase I. Bioorg Med Chem Lett (2007) 0.79

Insights on novel biologically active natural products: 7-isopentenyloxycoumarin. Nat Prod Commun (2009) 0.78

Identification and characterization of a new cell surface protein possessing factor H-binding activity in the swine pathogen and zoonotic agent Streptococcus suis. J Med Microbiol (2013) 0.78

Genome sequence of the swine pathogen Streptococcus suis serotype 2 strain S735. J Bacteriol (2012) 0.78

Monitoring the uptake of protein-derived peptides by Porphyromonas gingivalis with fluorophore-labeled substrates. Curr Microbiol (2003) 0.78

A-type cranberry proanthocyanidins inhibit the RANKL-dependent differentiation and function of human osteoclasts. Molecules (2011) 0.78

In vitro inhibitory activity of boropinic acid against Helicobacter pylori. Bioorg Med Chem Lett (2006) 0.78

Fibrinogen-induced streptococcus mutans biofilm formation and adherence to endothelial cells. Biomed Res Int (2013) 0.78

Neutralizing effect of green tea epigallocatechin-3-gallate on nicotine-induced toxicity and chemokine (C-C motif) ligand 5 secretion in human oral epithelial cells and fibroblasts. J Investig Clin Dent (2011) 0.77